1. Verthelyi D., Klinman D. M. Sex hormone levels correlate with the activity of cytokine‐secreting cells in vivo //Immunology. – 2000. – Т. 100. – №. 3. – С. 384-390.

2. Raghupathy R. Manipulation of cytokine production profiles as a therapeutic approach for immunologic pregnancy loss //Indian journal of biochemistry & biophysics. – 2008. – Т. 45. – №. 4. – С. 229-236.

3. Mekinian, A., Cohen, J., Kayem, G., Carbillon, L., Nicaise-Roland, P., Gaugler, B., & Fain, O. Unexplained recurrent early miscarriages: Role of immunomodulation? //La Revue de Medecine Interne. – 2016. – Т. 38. – №. 4. – С. 264-268.

4. Szekeres-Bartho J. Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage //Immunotherapy. – 2009. – Т. 1. – №. 5. – С. 873-882.

5. Raghupathy R., Szekeres-Bartho J. Dydrogesterone and the immunology of pregnancy //Hormone molecular biology and clinical investigation. – 2016. – Т. 27. – №. . – С. 63-71.

6. Szekeres‐Bartho, J., Faust, Z. S., Varga, P., Szereday, L., & Kelemen, K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production //American Journal of Reproductive Immunology. – 1996. – Т. 35. – №. 4. – С. 348-351.

7. Wahabi, H. A., Fayed, A. A., Esmaeil, S. A., & Bahkali, K. H. Progestogen for treating threatened miscarriage //Cochrane Database of Systematic Reviews. – 2018. – №. 8. – С. 47-51.